A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy

This study has been withdrawn prior to enrollment.

(PI moved to a new facility)

Sponsor:

Brigham and Women's Hospital

ClinicalTrials.gov Identifier:

NCT00401921

First Posted: November 22, 2006

Last Update Posted: July 14, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

The primary aim of this protocol is to investigate a possible new, neuroprotective treatment to prevent cognitive deficits that occur after carotid endarterectomy. We will investigate whether a widely used antibiotic agent - minocycline - that has shown neuroprotective effects in animal models of neurological diseases - can reduce the cognitive deficits associated with the surgical procedure of carotid endarterectomy (CEA). Because these cognitive deficits are believed to be a result of small strokes (due to emboli and/or hypoperfusion), this study will provide preliminary data on the use of this drug as a neuroprotective agent in stroke - a leading cause of disability.

(1) The first aim of this study is to examine whether 5 doses of minocycline administered 36 hrs before and 1 dose 12 hrs after the surgical procedure in patients undergoing CEA are effective to reduce the cognitive deficits associated with this procedure as compared with placebo.

a. The null hypothesis is that there is no difference in cognitive performance changes after CEA between the patients that receive placebo or minocycline.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

18 Years to 90 Years (Adult, Senior)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Patients with carotid stenosis 60% or more with a clinical indication of CEA.

Patients that can perform the tests in English.

Women of childbearing age must be non-lactating and surgically sterile or using an effective method of birth control and have a negative pregnancy test (adequate birth control includes use of intra uterine device, or a barrier method, e.g. condom, diaphragm).

Ages Eligible for Study: 18 Years - 90 Years

Genders Eligible for Study: Both

Exclusion Criteria:

Known hypersensitivity to tetracyclines

Advanced cardiac, pulmonary or renal disease as assessed by the PCP of the patient.

Previous strokes with important clinical neurological deficits.

Pregnancy, breast-feeding or lactating

Baseline MMSE score less or equal to 20.

Female subjects on oral contraceptives.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00401921